Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
It is aimed specifically at fat cells with no disruption of the general hormone network
The limited human data available indicate that both peptides appear to be generally well-tolerated, yet comprehensive safety and efficacy assessments from large, well-designed clinical trials are absent
This IGF-1 independence is the single most important experimental advantage of the AOD 9604 10mg research compound for researchers designing metabolic studies: the absence of IGF-1 elevation means that downstream anabolic, mitogenic, or glucose-modulating confounds associated with full-length hGH are not present in AOD-9604 experimental models
This visual indicator can help researchers assess compound integrity, though formal verification relies on the batch-specific Certificate of Analysis
First author Dr
CJC-1295 DAC (2 mg Vial) Long-acting GHRH analog for sustained growth hormone release.
US$ 20.88
US$ 28.56
US$ 29.01
